The rise of trispecific antibodies: Biopharma’s next big bet after bispecifics
Willow Shah-Neville
Discover the field of trispecific antibodies, which are currently generating strong interest across the biopharma industry. The post The rise of trispecific antibodies: Biopharma’s next big bet after bispecifics appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit i